Valovir (Valaciclovir)

Valovir is an antiviral medication containing valaciclovir, a prodrug of acyclovir used to treat infections caused by herpes simplex virus (HSV-1 and HSV-2) and varicella-zoster virus. This FDA/DOH/WHO-recommended. It is commonly prescribed for cold sores, genital herpes, shingles, and chickenpox in both adults and children.

Valaciclovir works by inhibiting viral DNA replication, reducing the severity and duration of outbreaks when taken during the prodromal phase or early stages of infection. The medication is also used for suppressive therapy to prevent recurrent herpes outbreaks in immunocompromised patients and those with frequent recurrences.

Available in tablet form, Valovir offers improved oral bioavailability compared to standard acyclovir, allowing for less frequent dosing schedules and better patient compliance. It is absorbed rapidly in the gastrointestinal tract and converted to acyclovir in the body for antiviral activity.

Valovir is suitable for episodic treatment of primary or recurrent HSV infections, as well as long-term suppressive therapy. Common dosing regimens vary based on indication, patient age, and renal function. The medication is generally well-tolerated with mild to moderate adverse effects.

This prescription antiviral is available through licensed pharmacies and requires a healthcare provider's prescription. It is essential to follow dosing instructions carefully and complete the full course of treatment for optimal therapeutic outcomes. Consult your healthcare professional regarding appropriate dosage, drug interactions, and contraindications before use.